Scott Cramer
Concepts (419)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 35 | 2022 | 927 | 4.200 |
Why?
| MAP Kinase Kinase Kinases | 8 | 2021 | 68 | 2.540 |
Why?
| Prostate | 10 | 2014 | 157 | 1.840 |
Why?
| Receptors, Androgen | 8 | 2021 | 132 | 1.290 |
Why?
| DNA Helicases | 4 | 2021 | 133 | 1.280 |
Why?
| Prostate-Specific Antigen | 9 | 2013 | 151 | 1.070 |
Why?
| Hyperoxaluria, Primary | 5 | 2009 | 14 | 0.990 |
Why?
| Epithelial Cells | 9 | 2016 | 961 | 0.960 |
Why?
| DNA-Binding Proteins | 5 | 2021 | 1316 | 0.910 |
Why?
| Calcitriol | 5 | 2011 | 53 | 0.890 |
Why?
| Alcohol Oxidoreductases | 7 | 2011 | 38 | 0.880 |
Why?
| Interleukin-1alpha | 2 | 2013 | 55 | 0.820 |
Why?
| Vitamin D | 3 | 2013 | 341 | 0.790 |
Why?
| Stromal Cells | 2 | 2014 | 97 | 0.700 |
Why?
| RNA Interference | 2 | 2021 | 438 | 0.680 |
Why?
| Homologous Recombination | 1 | 2019 | 21 | 0.670 |
Why?
| Androgens | 4 | 2021 | 165 | 0.630 |
Why?
| Cell Line, Tumor | 17 | 2021 | 2751 | 0.580 |
Why?
| Stem Cells | 3 | 2011 | 546 | 0.570 |
Why?
| DNA Damage | 1 | 2019 | 357 | 0.570 |
Why?
| Receptors, Calcitriol | 5 | 2015 | 53 | 0.540 |
Why?
| Tumor Suppressor Proteins | 2 | 2012 | 286 | 0.520 |
Why?
| Genomic Instability | 1 | 2015 | 38 | 0.510 |
Why?
| Epoxy Compounds | 2 | 2015 | 31 | 0.510 |
Why?
| Autophagy | 5 | 2020 | 236 | 0.510 |
Why?
| Carnitine O-Palmitoyltransferase | 2 | 2015 | 43 | 0.500 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1361 | 0.480 |
Why?
| Cell Division | 8 | 2011 | 759 | 0.480 |
Why?
| Anticarcinogenic Agents | 2 | 2014 | 67 | 0.480 |
Why?
| Signal Transduction | 7 | 2022 | 4541 | 0.460 |
Why?
| Breast | 2 | 2014 | 138 | 0.460 |
Why?
| Lactones | 1 | 2014 | 56 | 0.460 |
Why?
| Cell Proliferation | 9 | 2021 | 2194 | 0.440 |
Why?
| Mice | 25 | 2022 | 15052 | 0.430 |
Why?
| Nuclear Proteins | 2 | 2015 | 594 | 0.430 |
Why?
| Enzyme Inhibitors | 3 | 2014 | 757 | 0.430 |
Why?
| Animals | 34 | 2022 | 32102 | 0.420 |
Why?
| Male | 48 | 2022 | 55949 | 0.420 |
Why?
| Repressor Proteins | 1 | 2015 | 369 | 0.420 |
Why?
| Cells, Cultured | 13 | 2015 | 3914 | 0.400 |
Why?
| Mice, Knockout | 8 | 2015 | 2604 | 0.380 |
Why?
| Adult Stem Cells | 1 | 2011 | 32 | 0.380 |
Why?
| Intermediate Filament Proteins | 1 | 2011 | 66 | 0.370 |
Why?
| Neoplastic Stem Cells | 2 | 2011 | 331 | 0.370 |
Why?
| Chromones | 1 | 2010 | 35 | 0.370 |
Why?
| Polymorphism, Single Nucleotide | 7 | 2013 | 1918 | 0.360 |
Why?
| Necrosis | 4 | 2020 | 210 | 0.360 |
Why?
| Morpholines | 1 | 2010 | 103 | 0.350 |
Why?
| Nerve Tissue Proteins | 2 | 2011 | 535 | 0.340 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 400 | 0.330 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2011 | 208 | 0.310 |
Why?
| Cell Differentiation | 4 | 2014 | 1700 | 0.310 |
Why?
| Gene Deletion | 3 | 2011 | 355 | 0.310 |
Why?
| Humans | 56 | 2022 | 115587 | 0.310 |
Why?
| Neoplasm Invasiveness | 4 | 2015 | 445 | 0.310 |
Why?
| Pregnancy, Animal | 3 | 1992 | 52 | 0.300 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 1147 | 0.290 |
Why?
| Mutation, Missense | 3 | 2009 | 296 | 0.290 |
Why?
| Hyperoxaluria | 2 | 2011 | 3 | 0.280 |
Why?
| Promoter Regions, Genetic | 4 | 2009 | 1122 | 0.270 |
Why?
| Clinical Enzyme Tests | 1 | 2006 | 11 | 0.270 |
Why?
| Spectrophotometry | 1 | 2006 | 48 | 0.270 |
Why?
| Gene Expression Regulation | 6 | 2011 | 2353 | 0.270 |
Why?
| Pancreatic Neoplasms | 2 | 2011 | 722 | 0.270 |
Why?
| Prostatic Hyperplasia | 2 | 2004 | 38 | 0.270 |
Why?
| PTEN Phosphohydrolase | 5 | 2019 | 142 | 0.270 |
Why?
| Calcifediol | 3 | 2015 | 29 | 0.260 |
Why?
| Cell Lineage | 1 | 2007 | 310 | 0.260 |
Why?
| Biomarkers, Tumor | 4 | 2019 | 1048 | 0.250 |
Why?
| Genotype | 7 | 2008 | 1786 | 0.250 |
Why?
| Cell Cycle | 3 | 2021 | 546 | 0.240 |
Why?
| Genistein | 1 | 2004 | 12 | 0.230 |
Why?
| Fibroblasts | 2 | 2014 | 839 | 0.230 |
Why?
| Cyclins | 1 | 2004 | 79 | 0.230 |
Why?
| Allelic Imbalance | 1 | 2003 | 7 | 0.230 |
Why?
| Endocrinology | 1 | 2004 | 69 | 0.220 |
Why?
| Cell Cycle Proteins | 3 | 2010 | 553 | 0.220 |
Why?
| Proteins | 4 | 1997 | 920 | 0.220 |
Why?
| Specimen Handling | 1 | 2004 | 156 | 0.220 |
Why?
| Leukocytes, Mononuclear | 1 | 2006 | 501 | 0.220 |
Why?
| Polymorphism, Genetic | 2 | 2003 | 621 | 0.210 |
Why?
| Cell Communication | 1 | 2004 | 282 | 0.210 |
Why?
| Receptors, Somatotropin | 2 | 1992 | 8 | 0.210 |
Why?
| Linkage Disequilibrium | 1 | 2003 | 247 | 0.210 |
Why?
| Apoptosis | 6 | 2016 | 2377 | 0.210 |
Why?
| Neoplasm Recurrence, Local | 2 | 2021 | 863 | 0.200 |
Why?
| Parathyroid Hormone | 3 | 1997 | 95 | 0.190 |
Why?
| Neoplasms | 2 | 2014 | 2118 | 0.190 |
Why?
| Mutation | 3 | 2007 | 3364 | 0.190 |
Why?
| Phenylthiohydantoin | 1 | 2021 | 40 | 0.190 |
Why?
| Logistic Models | 2 | 2021 | 1856 | 0.190 |
Why?
| Prostatectomy | 2 | 2013 | 98 | 0.180 |
Why?
| Nitriles | 1 | 2021 | 152 | 0.180 |
Why?
| Benzamides | 1 | 2021 | 168 | 0.180 |
Why?
| Pyroptosis | 1 | 2020 | 2 | 0.180 |
Why?
| Cell Line | 7 | 2012 | 2651 | 0.180 |
Why?
| Carrier Proteins | 3 | 1992 | 701 | 0.170 |
Why?
| Colony-Forming Units Assay | 2 | 2011 | 90 | 0.170 |
Why?
| Cellular Senescence | 2 | 2011 | 153 | 0.170 |
Why?
| Immunoblotting | 3 | 2010 | 281 | 0.170 |
Why?
| Fluorescent Antibody Technique | 2 | 2013 | 398 | 0.160 |
Why?
| Molecular Sequence Data | 6 | 2009 | 2790 | 0.160 |
Why?
| Point Mutation | 1 | 1999 | 217 | 0.160 |
Why?
| ADP-ribosyl Cyclase 1 | 1 | 2018 | 35 | 0.160 |
Why?
| Osteoblasts | 2 | 1996 | 106 | 0.160 |
Why?
| Drug Resistance, Neoplasm | 2 | 2021 | 638 | 0.160 |
Why?
| Tumor Cells, Cultured | 6 | 2015 | 850 | 0.160 |
Why?
| Mice, Nude | 3 | 2015 | 639 | 0.160 |
Why?
| Genetic Markers | 2 | 2013 | 325 | 0.150 |
Why?
| RNA, Small Interfering | 3 | 2011 | 544 | 0.150 |
Why?
| NAD | 1 | 2018 | 67 | 0.150 |
Why?
| Regeneration | 2 | 2011 | 162 | 0.150 |
Why?
| Polymerase Chain Reaction | 5 | 2009 | 1000 | 0.150 |
Why?
| Meningeal Neoplasms | 1 | 2019 | 88 | 0.150 |
Why?
| Transfection | 5 | 2018 | 866 | 0.150 |
Why?
| Gene Expression | 5 | 2018 | 1435 | 0.150 |
Why?
| Membrane Glycoproteins | 2 | 2018 | 431 | 0.150 |
Why?
| Neoplasm Grading | 2 | 2015 | 244 | 0.140 |
Why?
| Drug Synergism | 2 | 2010 | 317 | 0.140 |
Why?
| Base Sequence | 6 | 2009 | 2114 | 0.140 |
Why?
| Cadherins | 2 | 2015 | 175 | 0.130 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2015 | 16 | 0.130 |
Why?
| Oxalates | 3 | 2011 | 10 | 0.130 |
Why?
| Cyclic AMP | 1 | 1996 | 227 | 0.130 |
Why?
| Transforming Growth Factor beta2 | 2 | 2014 | 31 | 0.130 |
Why?
| Recombination, Genetic | 2 | 2007 | 177 | 0.130 |
Why?
| Oncolytic Viruses | 1 | 2015 | 5 | 0.130 |
Why?
| Vesiculovirus | 1 | 2015 | 9 | 0.130 |
Why?
| Oncolytic Virotherapy | 1 | 2015 | 8 | 0.130 |
Why?
| Adenocarcinoma | 2 | 2019 | 799 | 0.120 |
Why?
| Lipid Metabolism | 2 | 2015 | 449 | 0.120 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2015 | 125 | 0.120 |
Why?
| Down-Regulation | 2 | 2014 | 601 | 0.120 |
Why?
| Oxidation-Reduction | 2 | 2015 | 924 | 0.120 |
Why?
| Endotoxins | 1 | 2015 | 207 | 0.120 |
Why?
| Liver | 3 | 2004 | 1690 | 0.120 |
Why?
| Metabolism | 1 | 2014 | 36 | 0.120 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2005 | 107 | 0.120 |
Why?
| Random Allocation | 1 | 2014 | 337 | 0.110 |
Why?
| Proto-Oncogenes | 1 | 2013 | 26 | 0.110 |
Why?
| Antineoplastic Agents | 1 | 2004 | 1893 | 0.110 |
Why?
| Litter Size | 1 | 1992 | 16 | 0.110 |
Why?
| Luciferases | 2 | 2003 | 140 | 0.110 |
Why?
| Flow Cytometry | 3 | 2011 | 1083 | 0.110 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 317 | 0.100 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 746 | 0.100 |
Why?
| DNA Copy Number Variations | 1 | 2013 | 156 | 0.100 |
Why?
| Silymarin | 1 | 2014 | 194 | 0.100 |
Why?
| Hydroxyproline | 1 | 2011 | 22 | 0.100 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2014 | 704 | 0.100 |
Why?
| Dietary Fats, Unsaturated | 1 | 2011 | 21 | 0.100 |
Why?
| Electrophoresis | 1 | 2011 | 25 | 0.100 |
Why?
| Genes, Retinoblastoma | 1 | 2011 | 8 | 0.100 |
Why?
| Genes, p16 | 1 | 2011 | 17 | 0.100 |
Why?
| Fatty Acids, Unsaturated | 1 | 2011 | 85 | 0.100 |
Why?
| Nestin | 1 | 2011 | 17 | 0.090 |
Why?
| Disease Progression | 2 | 2015 | 2418 | 0.090 |
Why?
| Microfluidic Analytical Techniques | 1 | 2011 | 72 | 0.090 |
Why?
| Ribonucleosides | 1 | 2010 | 6 | 0.090 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2011 | 91 | 0.090 |
Why?
| Brain Neoplasms | 1 | 2019 | 980 | 0.090 |
Why?
| Oxadiazoles | 1 | 2010 | 32 | 0.090 |
Why?
| Proto-Oncogene Proteins c-pim-1 | 1 | 2010 | 1 | 0.090 |
Why?
| S-Phase Kinase-Associated Proteins | 1 | 2010 | 18 | 0.090 |
Why?
| Organ Specificity | 1 | 2011 | 273 | 0.090 |
Why?
| Fatty Acids, Omega-3 | 1 | 2011 | 124 | 0.090 |
Why?
| Cell Separation | 1 | 2011 | 293 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 794 | 0.090 |
Why?
| Amino Acid Sequence | 3 | 2000 | 2000 | 0.090 |
Why?
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2010 | 15 | 0.090 |
Why?
| Glucose | 1 | 2015 | 904 | 0.090 |
Why?
| Hypoglycemic Agents | 2 | 2015 | 1008 | 0.090 |
Why?
| Endothelial Cells | 1 | 2015 | 695 | 0.090 |
Why?
| Hydroxypyruvate Reductase | 2 | 2000 | 2 | 0.090 |
Why?
| Expressed Sequence Tags | 2 | 2000 | 38 | 0.090 |
Why?
| Parathyroid Hormone-Related Protein | 4 | 1997 | 21 | 0.090 |
Why?
| YY1 Transcription Factor | 1 | 2009 | 27 | 0.080 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 3 | 2016 | 40 | 0.080 |
Why?
| DNA, Complementary | 2 | 2000 | 258 | 0.080 |
Why?
| Risk Factors | 2 | 2021 | 8697 | 0.080 |
Why?
| Prostatic Secretory Proteins | 1 | 2009 | 4 | 0.080 |
Why?
| Physical Chromosome Mapping | 1 | 2009 | 16 | 0.080 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2009 | 18 | 0.080 |
Why?
| Sequence Homology, Amino Acid | 2 | 2000 | 352 | 0.080 |
Why?
| RNA-Binding Proteins | 3 | 2022 | 362 | 0.080 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 332 | 0.080 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 249 | 0.080 |
Why?
| Rats | 4 | 2015 | 5034 | 0.080 |
Why?
| Ataxins | 1 | 2007 | 3 | 0.080 |
Why?
| Ataxin-1 | 1 | 2007 | 4 | 0.080 |
Why?
| Integrin alpha6 | 1 | 2007 | 8 | 0.080 |
Why?
| Genetic Predisposition to Disease | 4 | 2009 | 2125 | 0.080 |
Why?
| Growth Hormone | 3 | 1992 | 99 | 0.080 |
Why?
| Cell Movement | 1 | 2012 | 867 | 0.070 |
Why?
| Gene Frequency | 1 | 2009 | 485 | 0.070 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 390 | 0.070 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2007 | 44 | 0.070 |
Why?
| Middle Aged | 8 | 2013 | 26999 | 0.070 |
Why?
| Response Elements | 2 | 2009 | 83 | 0.070 |
Why?
| Culture Media, Serum-Free | 2 | 2005 | 42 | 0.070 |
Why?
| Clone Cells | 1 | 2007 | 248 | 0.070 |
Why?
| Chromosome Deletion | 1 | 2007 | 95 | 0.070 |
Why?
| Chi-Square Distribution | 1 | 2008 | 499 | 0.070 |
Why?
| Japan | 1 | 2007 | 88 | 0.070 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2016 | 13 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 930 | 0.070 |
Why?
| Carbohydrate Dehydrogenases | 1 | 2006 | 11 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 1 | 2010 | 1870 | 0.070 |
Why?
| RNA, Messenger | 5 | 2011 | 2574 | 0.070 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 346 | 0.070 |
Why?
| Blotting, Western | 2 | 2006 | 1153 | 0.070 |
Why?
| Genetic Vectors | 1 | 2007 | 290 | 0.070 |
Why?
| Receptors, Eicosanoid | 1 | 2005 | 1 | 0.070 |
Why?
| Alleles | 1 | 2008 | 794 | 0.060 |
Why?
| Arachidonic Acids | 1 | 2005 | 58 | 0.060 |
Why?
| Prostatic Diseases | 1 | 2005 | 4 | 0.060 |
Why?
| Parainfluenza Virus 5 | 1 | 2005 | 1 | 0.060 |
Why?
| Viral Structural Proteins | 1 | 2005 | 12 | 0.060 |
Why?
| Adult | 6 | 2013 | 30718 | 0.060 |
Why?
| Vesicular stomatitis Indiana virus | 1 | 2004 | 13 | 0.060 |
Why?
| Viral Matrix Proteins | 1 | 2004 | 24 | 0.060 |
Why?
| Tolonium Chloride | 1 | 2004 | 3 | 0.060 |
Why?
| ADP Ribose Transferases | 1 | 2004 | 8 | 0.060 |
Why?
| Glycolates | 1 | 2004 | 3 | 0.060 |
Why?
| DNA Mutational Analysis | 2 | 2009 | 372 | 0.060 |
Why?
| Glyoxylates | 1 | 2004 | 9 | 0.060 |
Why?
| Reference Values | 1 | 2006 | 744 | 0.060 |
Why?
| Coloring Agents | 1 | 2004 | 71 | 0.060 |
Why?
| Lung | 2 | 2015 | 3672 | 0.060 |
Why?
| Calcium Channel Agonists | 1 | 2004 | 10 | 0.060 |
Why?
| Interferon Type I | 1 | 2005 | 129 | 0.060 |
Why?
| Steroid Hydroxylases | 1 | 2004 | 19 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2013 | 1805 | 0.060 |
Why?
| MicroRNAs | 1 | 2010 | 607 | 0.060 |
Why?
| Ergocalciferols | 1 | 2003 | 11 | 0.060 |
Why?
| beta-Galactosidase | 1 | 2003 | 63 | 0.060 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2004 | 108 | 0.060 |
Why?
| Radiation-Sensitizing Agents | 1 | 2003 | 38 | 0.060 |
Why?
| Transcription, Genetic | 1 | 2009 | 1310 | 0.060 |
Why?
| Microscopy, Fluorescence | 1 | 2005 | 402 | 0.060 |
Why?
| Analysis of Variance | 2 | 2003 | 1227 | 0.060 |
Why?
| Palpation | 1 | 2003 | 12 | 0.050 |
Why?
| Trinucleotide Repeats | 1 | 2003 | 24 | 0.050 |
Why?
| Reproducibility of Results | 2 | 2011 | 2800 | 0.050 |
Why?
| Gene Amplification | 1 | 2003 | 96 | 0.050 |
Why?
| Phosphoproteins | 1 | 2005 | 304 | 0.050 |
Why?
| Viral Proteins | 1 | 2005 | 286 | 0.050 |
Why?
| Cell Culture Techniques | 1 | 2005 | 344 | 0.050 |
Why?
| Up-Regulation | 2 | 2004 | 820 | 0.050 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2002 | 69 | 0.050 |
Why?
| Radioimmunoassay | 2 | 1992 | 163 | 0.050 |
Why?
| Transcription Factors | 1 | 2010 | 1528 | 0.050 |
Why?
| Peptide Elongation Factors | 1 | 2022 | 13 | 0.050 |
Why?
| Genes, Tumor Suppressor | 1 | 2002 | 78 | 0.050 |
Why?
| Transforming Growth Factor beta | 1 | 2005 | 446 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2003 | 523 | 0.050 |
Why?
| Aged | 6 | 2013 | 19251 | 0.050 |
Why?
| Embryo, Mammalian | 1 | 2002 | 214 | 0.050 |
Why?
| Haplotypes | 1 | 2003 | 457 | 0.050 |
Why?
| Vitamin D3 24-Hydroxylase | 2 | 2015 | 14 | 0.050 |
Why?
| In Vitro Techniques | 1 | 2003 | 1044 | 0.050 |
Why?
| Kinetics | 2 | 1996 | 1569 | 0.050 |
Why?
| Founder Effect | 1 | 2000 | 13 | 0.050 |
Why?
| Sequence Analysis, DNA | 1 | 2003 | 732 | 0.040 |
Why?
| Codon, Nonsense | 1 | 2000 | 38 | 0.040 |
Why?
| Multienzyme Complexes | 1 | 2000 | 64 | 0.040 |
Why?
| Glyceric Acids | 1 | 2000 | 6 | 0.040 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2000 | 43 | 0.040 |
Why?
| Microsatellite Repeats | 1 | 2000 | 137 | 0.040 |
Why?
| Mixed Function Oxygenases | 1 | 2000 | 37 | 0.040 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 1999 | 27 | 0.040 |
Why?
| Consensus Sequence | 1 | 1999 | 70 | 0.040 |
Why?
| Gene Knockdown Techniques | 2 | 2011 | 302 | 0.040 |
Why?
| Time Factors | 4 | 2009 | 6165 | 0.040 |
Why?
| Chemoprevention | 1 | 2000 | 88 | 0.040 |
Why?
| Trans-Activators | 1 | 2022 | 370 | 0.040 |
Why?
| COS Cells | 1 | 1999 | 175 | 0.040 |
Why?
| Codon | 1 | 1999 | 86 | 0.040 |
Why?
| Phenotype | 1 | 2007 | 2829 | 0.040 |
Why?
| Genes | 1 | 1999 | 224 | 0.040 |
Why?
| Parenchymal Tissue | 1 | 2019 | 6 | 0.040 |
Why?
| Transcriptional Regulator ERG | 1 | 2019 | 11 | 0.040 |
Why?
| Cell Death | 2 | 2015 | 326 | 0.040 |
Why?
| Tissue Distribution | 1 | 2000 | 324 | 0.040 |
Why?
| Green Fluorescent Proteins | 2 | 2015 | 377 | 0.040 |
Why?
| Sweden | 2 | 2009 | 65 | 0.040 |
Why?
| Sequence Alignment | 1 | 1999 | 327 | 0.040 |
Why?
| Nicotinamide Phosphoribosyltransferase | 1 | 2018 | 6 | 0.040 |
Why?
| Exons | 1 | 1999 | 300 | 0.040 |
Why?
| Transaminases | 2 | 2011 | 25 | 0.040 |
Why?
| Serine Endopeptidases | 1 | 2019 | 102 | 0.040 |
Why?
| Acrylamides | 1 | 2018 | 43 | 0.040 |
Why?
| Species Specificity | 1 | 1999 | 552 | 0.040 |
Why?
| Cellular Reprogramming | 1 | 2018 | 84 | 0.040 |
Why?
| Tretinoin | 1 | 2018 | 124 | 0.040 |
Why?
| Mitochondria | 2 | 2018 | 750 | 0.040 |
Why?
| Recombinant Proteins | 2 | 2015 | 1243 | 0.040 |
Why?
| Biomarkers | 1 | 2007 | 3466 | 0.040 |
Why?
| Prevalence | 1 | 2003 | 2264 | 0.040 |
Why?
| Piperidines | 1 | 2018 | 163 | 0.040 |
Why?
| Autophagy-Related Protein 5 | 1 | 2016 | 5 | 0.030 |
Why?
| Receptors, Death Domain | 1 | 2016 | 3 | 0.030 |
Why?
| Autophagosomes | 1 | 2016 | 19 | 0.030 |
Why?
| Pregnancy | 3 | 1992 | 5548 | 0.030 |
Why?
| Protein Kinases | 1 | 2018 | 306 | 0.030 |
Why?
| Culture Media | 1 | 1996 | 156 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 1996 | 161 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2005 | 3580 | 0.030 |
Why?
| Cell Survival | 2 | 2011 | 1024 | 0.030 |
Why?
| Fatty Acids | 1 | 2018 | 386 | 0.030 |
Why?
| Epithelium | 1 | 1996 | 297 | 0.030 |
Why?
| Genes, Viral | 1 | 2015 | 89 | 0.030 |
Why?
| Heterografts | 1 | 2015 | 119 | 0.030 |
Why?
| STAT1 Transcription Factor | 1 | 2015 | 64 | 0.030 |
Why?
| Poly(ADP-ribose) Polymerases | 2 | 2005 | 88 | 0.030 |
Why?
| Female | 5 | 2006 | 59913 | 0.030 |
Why?
| Lipids | 1 | 2018 | 588 | 0.030 |
Why?
| Caspases | 2 | 2005 | 245 | 0.030 |
Why?
| Positron-Emission Tomography | 1 | 2015 | 284 | 0.030 |
Why?
| Sheep | 1 | 2015 | 764 | 0.030 |
Why?
| Transcriptome | 1 | 2018 | 736 | 0.030 |
Why?
| Placental Lactogen | 1 | 1992 | 20 | 0.030 |
Why?
| Protein Binding | 2 | 2010 | 1917 | 0.030 |
Why?
| Models, Biological | 1 | 2000 | 1646 | 0.030 |
Why?
| Microsomes, Liver | 1 | 1992 | 57 | 0.030 |
Why?
| Blotting, Northern | 1 | 1992 | 194 | 0.030 |
Why?
| Nephrocalcinosis | 1 | 2011 | 2 | 0.030 |
Why?
| Immunohistochemistry | 1 | 1996 | 1642 | 0.030 |
Why?
| Binding, Competitive | 1 | 1992 | 200 | 0.020 |
Why?
| Animal Feed | 1 | 2011 | 50 | 0.020 |
Why?
| Orchiectomy | 1 | 2011 | 57 | 0.020 |
Why?
| Sensitivity and Specificity | 2 | 2009 | 1718 | 0.020 |
Why?
| Fatty Acid Desaturases | 1 | 2011 | 30 | 0.020 |
Why?
| Gene Knockout Techniques | 1 | 2011 | 99 | 0.020 |
Why?
| Fatty Acids, Omega-6 | 1 | 2011 | 46 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2011 | 187 | 0.020 |
Why?
| Neoplasm Transplantation | 1 | 2011 | 235 | 0.020 |
Why?
| Homozygote | 1 | 2011 | 186 | 0.020 |
Why?
| Spheroids, Cellular | 1 | 2011 | 57 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2011 | 136 | 0.020 |
Why?
| Proteolysis | 1 | 2011 | 145 | 0.020 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2015 | 330 | 0.020 |
Why?
| Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2010 | 1 | 0.020 |
Why?
| Peptide Fragments | 1 | 1995 | 675 | 0.020 |
Why?
| Cytokines | 1 | 2018 | 1853 | 0.020 |
Why?
| Rabbits | 1 | 1992 | 752 | 0.020 |
Why?
| S Phase | 1 | 2010 | 69 | 0.020 |
Why?
| Odds Ratio | 1 | 2013 | 962 | 0.020 |
Why?
| Enhancer of Zeste Homolog 2 Protein | 1 | 2010 | 37 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2015 | 2262 | 0.020 |
Why?
| Ubiquitination | 1 | 2010 | 86 | 0.020 |
Why?
| Antioxidants | 1 | 2014 | 533 | 0.020 |
Why?
| Neovascularization, Pathologic | 1 | 2011 | 283 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 312 | 0.020 |
Why?
| Case-Control Studies | 2 | 2009 | 3022 | 0.020 |
Why?
| Pulmonary Artery | 1 | 2015 | 1031 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2013 | 1178 | 0.020 |
Why?
| HEK293 Cells | 1 | 2011 | 602 | 0.020 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2010 | 59 | 0.020 |
Why?
| HeLa Cells | 1 | 2010 | 567 | 0.020 |
Why?
| Antigens, CD | 1 | 2010 | 442 | 0.020 |
Why?
| Computer Simulation | 1 | 2011 | 881 | 0.020 |
Why?
| Enzyme Activation | 1 | 2009 | 793 | 0.020 |
Why?
| Placenta | 1 | 1992 | 624 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2011 | 1970 | 0.020 |
Why?
| Phosphorylation | 1 | 2010 | 1571 | 0.020 |
Why?
| Pertussis Toxin | 1 | 2005 | 26 | 0.020 |
Why?
| Peroxisome Proliferator-Activated Receptors | 1 | 2005 | 15 | 0.020 |
Why?
| Prostaglandin D2 | 1 | 2005 | 21 | 0.020 |
Why?
| Hydroxyeicosatetraenoic Acids | 1 | 2005 | 40 | 0.020 |
Why?
| Prognosis | 1 | 2013 | 3339 | 0.020 |
Why?
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2005 | 40 | 0.020 |
Why?
| Anilides | 1 | 2005 | 67 | 0.020 |
Why?
| Fas-Associated Death Domain Protein | 1 | 2005 | 8 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2009 | 1440 | 0.020 |
Why?
| ADP-Ribosylation Factors | 1 | 2005 | 16 | 0.020 |
Why?
| Caspase 8 | 1 | 2005 | 43 | 0.020 |
Why?
| DNA Fragmentation | 1 | 2004 | 47 | 0.020 |
Why?
| Retinoblastoma Protein | 1 | 2005 | 52 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 58 | 0.020 |
Why?
| Diet | 1 | 2011 | 1072 | 0.020 |
Why?
| Peroxisomes | 1 | 2004 | 9 | 0.020 |
Why?
| Caspase 3 | 1 | 2005 | 237 | 0.010 |
Why?
| Mitosis | 1 | 2005 | 164 | 0.010 |
Why?
| L-Lactate Dehydrogenase | 1 | 2004 | 107 | 0.010 |
Why?
| Microscopy, Electron | 1 | 2005 | 409 | 0.010 |
Why?
| PPAR gamma | 1 | 2005 | 185 | 0.010 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2005 | 174 | 0.010 |
Why?
| Adenoviridae | 1 | 2005 | 186 | 0.010 |
Why?
| Models, Molecular | 1 | 2009 | 1390 | 0.010 |
Why?
| Radiation, Ionizing | 1 | 2003 | 73 | 0.010 |
Why?
| Carcinoma | 1 | 2005 | 200 | 0.010 |
Why?
| DNA, Neoplasm | 1 | 2003 | 157 | 0.010 |
Why?
| Phagocytosis | 1 | 2005 | 355 | 0.010 |
Why?
| DNA Primers | 1 | 2004 | 514 | 0.010 |
Why?
| Virus Replication | 1 | 2004 | 396 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2005 | 804 | 0.010 |
Why?
| Retrospective Studies | 1 | 2019 | 12608 | 0.010 |
Why?
| Binding Sites | 1 | 2005 | 1177 | 0.010 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 388 | 0.010 |
Why?
| Cattle | 1 | 2005 | 935 | 0.010 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 374 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 1168 | 0.010 |
Why?
| Probability | 1 | 2002 | 294 | 0.010 |
Why?
| Registries | 1 | 2009 | 1770 | 0.010 |
Why?
| Inflammation | 1 | 2011 | 2499 | 0.010 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2005 | 449 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1137 | 0.010 |
Why?
| Genetic Variation | 1 | 2004 | 877 | 0.010 |
Why?
| Cell Count | 1 | 1997 | 305 | 0.010 |
Why?
| Teriparatide | 1 | 1995 | 4 | 0.010 |
Why?
| Phorbol Esters | 1 | 1995 | 15 | 0.010 |
Why?
| Colforsin | 1 | 1995 | 46 | 0.010 |
Why?
| Second Messenger Systems | 1 | 1995 | 32 | 0.010 |
Why?
| Osteosarcoma | 1 | 1995 | 66 | 0.010 |
Why?
| Brain | 1 | 2004 | 2370 | 0.010 |
Why?
| Cohort Studies | 1 | 2002 | 4944 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2002 | 6417 | 0.010 |
Why?
| Prospective Studies | 1 | 2002 | 6264 | 0.010 |
Why?
|
|
Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|